A Controlled Intervention Study with Antibiotics in Symptomatic Coronary Patients Irrespective of Serology
Since the first coronary artery bypass surgery in 1967, 30 years have passed with few medical strategies proven effective in the treatment of acute coronary syndromes [1, 2]. In spite of it and many new antithrombotic compounds, a sizable proportion of patients are still developing new ischemic episodes, which may indicate that we have reached a biological barrier where any attempt to increase efficacy leads to the loss of security.
KeywordsAcute Coronary Syndrome Human Leukocyte Antigen Coronary Artery Bypass Surgery Macrolide Antibiotic Clin Drug Invest
Unable to display preview. Download preview PDF.
- 4.Gurfinkel E, Bozovich G, Livellara G, Beck E, Testa E, Mautner B (1999) Antibiotics for the treatment of non-Q-wave coronary syndromes. The Final Report of the ROXIS Trial. Eur Heart J 15: 368–380Google Scholar
- 6.Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS (1998) Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 19: 387–394PubMedCrossRefGoogle Scholar
- 7.Bozovich G, Gurfinkel E, Raimondi E, Padrós K, Mejaíl I, Haas E et al (1997) Major histocompatibility complex and the vulnerable plaque in acute coronary syndromes. Potential modulation of the inflammatory response. Puerto Rico Health Sciences Journal 16: 5Google Scholar
- 8.Kadota JL (1996) Non-antibiotic effects of antibiotics. J Clin Microb Infect [Suppl II]: 220-222Google Scholar